10/28《生醫焦點雷達》

2024-10-28 / 新聞中心

健保署：醫療自費平台明年初有望上路付費資訊更透明聯合報2024/10/26石化集團大舉布局健康醫療工商時報2024/10/28可成旗下可力生醫取得CDMO營業資產策略轉型再下一城鉅亨網2024/10/25保瑞2725萬美元收購美罕藥公司Pyros估Q4完成環球生技2024/10/28丁丁藥局攜慧穎生醫搶攻輕齡市場工商時報2024/10/25保誠將在星馬使用GoogleCloudMedLM處理醫療...

新聞集錦

08/29《生醫焦點雷達》

2024-08-29 / 新聞中心

行政院生技產業策略諮議委員會議新藥從台灣製造升級為台灣創造聯合報2024/8/28BTC提出臺灣智慧醫療發展建議，強調AI新藥設計、次世代醫療IT系統開發iThome2024/8/28美降息近生技股先受惠！每季平均股價表現優於大盤4％～5％工商時報2024/8/29中天上海收到華潤雙鶴第一期「速必一」授權首付款6.5億元經濟日報2024/8/28癌篩奏效去年揪出逾3萬癌前病變聯合報2024/8/2...

GBIHighlights

Merck Group's M Lab™ Collaboration Center has arrived in Taipei

2023-12-01 / GlobalBio & Investment

MerckGroup'sMLab™CollaborationCenterhasarrivedinTaipei,shiningaspotlightonthecity'svibrantbiopharmapotential.Experiencethechancetocollaboratewithexpertengineersandscientists,conquerbioph...

EV AML

《Nature》子刊: 4D揭示大型內皮細胞源性EV生成過程

2024-10-31 / 記者黃佳啟

美國時間22日，澳洲研究團隊利用骨髓活體顯微鏡(intravitalmicroscopy)在穩定狀態以及惡性病變條件下，測量由內皮細胞產成大型細胞外囊泡(EV)的動力學。該研究透過小鼠模型，呈現出內皮細胞源性EV的產生過程和時空特徵，並揭示了大型內皮細胞源性EV在原位形成的頻率及其在各個器官中的分布。該研究結果刊登於《NatureCommunication》。內皮細胞排列於血管管壁上，長期暴露於...

GBIHighlights

Taiwan's First Agri-Food Circular Factory Unveiled!

2023-12-01 / GlobalBio & Investment

Taiwan'sFirstAgri-FoodCircularFactoryUnveiled! Inamilestonemove,thefirst-everAgri-FoodCircularConceptFactorycommencedoperationsintheindustrialzonein #Pingtung.Thefacilityincorporatesa #Compal AIoT...

GBIHighlights

Forum addressing "How to become an interdisciplinary biomedical talent"

2024-07-19 / GlobalBio & Investment

Thisafternoon,TiBIA(TaiwanBiomedicalInnovationAssociation)andGlobalBio&InvestmentMonthlyheldaforumaddressing"howtobecomeaninterdisciplinarybiomedicaltalent",andinvitedthreerepresentative...

GBIHighlights

Genomics secured exclusive distribution rights for products from Thermo Fisher Scientific's LPD

2024-03-31 / GlobalBio & Investment

#LabTestingAdvancementsGenomicsBioSci&TechCoLtd(Genomics)hasbeenmakingsignificantstrides!Asthedemandforlaboratoryexpansiongrows,#Genomicshassecuredexclusivedistributionrightsforselectedproductsfro...

禮來嬌生潰瘍性結腸炎克隆氏症 IL-23 Omvoh Tremfya

IL-23抑制劑競爭禮來Omvoh對陣嬌生Tremfya

2024-10-29 / 記者黃佳啟

美國時間28日，在等待美國食品藥物管理局(FDA)是否會擴大介白素IL-23抑制劑的適用範圍至克隆氏症(Crohn'sdisease)的消息時，禮來(EliLilly)和嬌生(J&J)在美國胃腸病學會(ACR)會議上公布了各自臨床數據。禮來的IL-23p19拮抗劑Omvoh(mirikizumab)顯示出長達五年的持續療效。嬌生的Tremfya(guselkumab)能與IL-23...

GBIHighlights

BIO Asia–Taiwan starts today!

2024-07-24 / GlobalBio & Investment

BIOAsia–Taiwan亞洲生技大會startstoday!PleasefollowusandstaytunedtoourspecialreportsofBIO-AsiaTaiwan2024.Theconferencethemethisyearis"GlobalView,AsianTouch".Manyspecialguestsfromabroadcametot...

GBIHighlights

Prix Galien Award, Nobel of Biopharmaceuticals Unveils Top Medical Products

2023-12-01 / GlobalBio & Investment

PrixGalienAward,NobelofBiopharmaceuticalsUnveilsTopMedicalProducts,fromCAR-TtoCOVID-19Vaccine.TheUKheldthePrixGalienAwardceremonyafewdaysago,whichisknownasthehighesthonorinthepharmaceuticalindustry.Th...

GBIHighlights

Discover Taiwan's showcased medical device 'hidden champions' at MEDICA

2023-12-01 / GlobalBio & Investment

FairslikeMEDICAconnectuswithasharedgoalofadvancinghealthcareandwell-being.DiscoverTaiwan'sshowcasedmedicaldevice'hiddenchampions'attheexhibition.https://lnkd.in/gy4UEEAa#MEDICA2023 #MEDICA...

GBIHighlights

Medical Taiwan 2024 Wraps Up with Record-Breaking Attendance

2024-07-17 / GlobalBio & Investment

MedicalTaiwan2024WrapsUpwithRecord-BreakingAttendance!MedicalTaiwan2024wrappeduponJune21,attractingover8,000visitors,a10%increasefromlastyear,withnearly1,000internationalattendeesfromJapan,Thailand,Ko...